China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Symbol: 000999.SZ
SHZ
60.44
CNYDzisiejsza cena rynkowa
19.3562
Wskaźnik P/E
0.6713
Wskaźnik PEG
59.16B
Kapitalizacja MRK
- 0.02%
Rentowność DIV
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 31131.85 | 8226.8 | 3149.7 | 4283.9 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 4438.4 | 1873.3 | -2647.1 | 1218.8 | |||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 35661.86 | 8581.2 | 6071.3 | 5659.4 | |||||||||||||||||||||||||||
balance-sheet.row.inventory | 19561.08 | 5112.5 | 2498.9 | 2308.5 | |||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 2087.77 | 601.5 | 268.6 | 226.6 | |||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 88442.55 | 22522 | 11988.5 | 12478.4 | |||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 26485.4 | 6802.6 | 4823 | 4237.8 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill | 20610.44 | 5123.9 | 3994.9 | 4060.4 | |||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 16356.23 | 4078.3 | 2749.9 | 2646.6 | |||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 36966.68 | 9202.2 | 6744.7 | 6707 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2002.87 | 724.9 | 2948.1 | -980.1 | |||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 2492.53 | 626.8 | 324.5 | 241.4 | |||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 2569.73 | 270 | 293.9 | 1623.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 70517.2 | 17626.5 | 15134.3 | 11829.6 | |||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.total-assets | 158959.75 | 40148.5 | 27122.8 | 24308 | |||||||||||||||||||||||||||
balance-sheet.row.account-payables | 10661.5 | 2365.2 | 1795.1 | 1415.8 | |||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 6351.27 | 2019.9 | 235.1 | 110.7 | |||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 1709.78 | 254.5 | 518.1 | 373.9 | |||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 7337.29 | 1802.9 | 156 | 96.7 | |||||||||||||||||||||||||||
Deferred Revenue Non Current | 2242.3 | 455.5 | 423.2 | 395.1 | |||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1527.48 | - | - | - | |||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 14138.21 | 6911.7 | 5630.2 | 234.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 11689.15 | 2474.3 | 916.7 | 819.8 | |||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 494.4 | 119.5 | 105.8 | 88.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-liab | 61904.84 | 15421.2 | 9589.4 | 8595.3 | |||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
balance-sheet.row.common-stock | 3952.9 | 988.2 | 988.3 | 978.9 | |||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 62863.05 | 16047.3 | 13761.4 | 12131.5 | |||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 6444.97 | 754.6 | 673.1 | 549.3 | |||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2509.22 | 1177 | 1586.7 | 1622.9 | |||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 75770.14 | 18967.1 | 17009.6 | 15282.5 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 158959.75 | 40148.5 | 27122.8 | 24308 | |||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 20819.42 | 5294.7 | 523.8 | 430.2 | |||||||||||||||||||||||||||
balance-sheet.row.total-equity | 96589.56 | 24261.9 | 17533.4 | 15712.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 158959.75 | - | - | - | |||||||||||||||||||||||||||
Total Investments | 6441.27 | 2598.3 | 301 | 238.7 | |||||||||||||||||||||||||||
balance-sheet.row.total-debt | 13908.27 | 3942.3 | 391.1 | 207.4 | |||||||||||||||||||||||||||
balance-sheet.row.net-debt | -12785.17 | -2411.2 | -2758.6 | -2857.7 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 3065.73 | 2852.9 | 2497 | 2080.8 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 54.35 | 853.7 | 522.7 | 476.2 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -74.4 | -137.7 | -63.5 | -87 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 82.91 | -1724.5 | 63.5 | 87 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -332.32 | -17 | -216.9 | -946.9 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 633.69 | 633.7 | -71.8 | -674.7 | |||||||||||||||||||||||||
cash-flows.row.inventory | -966.01 | -966 | -59.7 | -664.9 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 315.3 | -21.9 | 458.4 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -63.5 | -65.7 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 1989.6 | 2393 | 203.5 | 260.3 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 4707.2 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -780.38 | -857.2 | -951.6 | -870.8 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 25.56 | 31.1 | -11.8 | -120.6 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -4195.27 | -3182 | -5675.9 | -5203.2 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 2908.42 | 2228.6 | 4152.1 | 4394.8 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -284.8 | 957.8 | 8 | 9.3 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2326.47 | -821.7 | -2479.2 | -1790.5 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | -1446.58 | -1741.8 | -462.2 | -28.5 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0.28 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.28 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | -1076.37 | -988.3 | -855.8 | -491.8 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 3351.22 | 3180.1 | 742.5 | -132.8 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -97.65 | 450 | -575.5 | -653.1 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 4.94 | 5 | 6.3 | -2.3 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 2101.65 | 3203.7 | -41.9 | -575.4 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 25499.51 | 6353.5 | 2361.4 | 2403.2 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 23397.85 | 3149.7 | 2403.4 | 2978.7 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 4707.2 | 4220.4 | 3006.4 | 1870.5 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -780.38 | -857.2 | -951.6 | -870.8 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 3926.82 | 3363.2 | 2054.8 | 999.7 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 25524.28 | 24464 | 18079.5 | 15320 | |||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 12125.74 | 11859.7 | 8313.1 | 6170.8 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 13398.55 | 12604.4 | 9766.3 | 9149.2 | |||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
income-statement-row.row.research-development | 700.37 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 380.93 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 7123.52 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -161.15 | -108.2 | 792.5 | 662.2 | |||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 9498.49 | 9080.3 | 6717 | 6497.6 | |||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 21624.23 | 20940 | 15030.2 | 12668.4 | |||||||||||||||||||||||||||
income-statement-row.row.interest-income | 76.05 | 106.9 | 73.5 | 67 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 91.89 | 80.8 | 21.2 | 13.3 | |||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 7123.52 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 192.28 | 225.2 | 16.2 | -28.4 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -161.15 | -108.2 | 792.5 | 662.2 | |||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 192.28 | 225.2 | 16.2 | -28.4 | |||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 91.89 | 80.8 | 21.2 | 13.3 | |||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 510.85 | 853.7 | 704 | 729.5 | |||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 4353.5 | - | - | - | |||||||||||||||||||||||||||
income-statement-row.row.operating-income | 3856.84 | 3524 | 2947.2 | 2457.4 | |||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 4049.12 | 3749.2 | 2963.4 | 2429.1 | |||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 650.56 | 581 | 466.4 | 348.2 | |||||||||||||||||||||||||||
income-statement-row.row.net-income | 3065.73 | 2852.9 | 2448.8 | 2055.1 |
Często zadawane pytania
Ile wynosi China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) aktywów ogółem?
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) całkowite aktywa to 40148455933.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 13268686742.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.525.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 4.011.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.120.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.151.
Co to jest China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 2852931664.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 3942294961.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 9080313650.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 7026231386.000.